19-1220597-C-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM1BP6BS2

The NM_000455.5(STK11):​c.614C>T​(p.Ala205Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000258 in 1,590,130 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A205T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

STK11
NM_000455.5 missense

Scores

2
9
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:4

Conservation

PhyloP100: 7.80

Publications

3 publications found
Variant links:
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
STK11 Gene-Disease associations (from GenCC):
  • familial pancreatic carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Peutz-Jeghers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM1
In a domain Protein kinase (size 260) in uniprot entity STK11_HUMAN there are 64 pathogenic changes around while only 21 benign (75%) in NM_000455.5
BP6
Variant 19-1220597-C-T is Benign according to our data. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443. Variant chr19-1220597-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 142443.
BS2
High AC in GnomAdExome4 at 39 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK11NM_000455.5 linkc.614C>T p.Ala205Val missense_variant Exon 5 of 10 ENST00000326873.12 NP_000446.1 Q15831-1A0A0S2Z4D1
STK11NM_001407255.1 linkc.614C>T p.Ala205Val missense_variant Exon 5 of 9 NP_001394184.1
STK11NR_176325.1 linkn.1881C>T non_coding_transcript_exon_variant Exon 6 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK11ENST00000326873.12 linkc.614C>T p.Ala205Val missense_variant Exon 5 of 10 1 NM_000455.5 ENSP00000324856.6 Q15831-1
STK11ENST00000652231.1 linkc.614C>T p.Ala205Val missense_variant Exon 5 of 9 ENSP00000498804.1 Q15831-2
STK11ENST00000585748.3 linkc.242C>T p.Ala81Val missense_variant Exon 7 of 12 3 ENSP00000477641.2 A0A087WT72
STK11ENST00000593219.6 linkn.*439C>T non_coding_transcript_exon_variant Exon 6 of 11 3 ENSP00000466610.1 K7EMR0
STK11ENST00000593219.6 linkn.*439C>T 3_prime_UTR_variant Exon 6 of 11 3 ENSP00000466610.1 K7EMR0

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152192
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000191
AC:
4
AN:
209296
AF XY:
0.00000869
show subpopulations
Gnomad AFR exome
AF:
0.0000877
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000328
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000271
AC:
39
AN:
1437938
Hom.:
0
Cov.:
32
AF XY:
0.0000182
AC XY:
13
AN XY:
713142
show subpopulations
African (AFR)
AF:
0.0000910
AC:
3
AN:
32972
American (AMR)
AF:
0.00
AC:
0
AN:
41472
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25540
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38546
South Asian (SAS)
AF:
0.0000239
AC:
2
AN:
83786
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50154
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5658
European-Non Finnish (NFE)
AF:
0.0000309
AC:
34
AN:
1100516
Other (OTH)
AF:
0.00
AC:
0
AN:
59294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152192
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41446
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.00000844
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:8Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Peutz-Jeghers syndrome Uncertain:6Benign:1
Apr 14, 2023
Myriad Genetics, Inc.
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. -

Jul 08, 2022
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

_x000D_ Criteria applied: PM2_SUP, PP3 -

Nov 23, 2015
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Jun 04, 2025
Molecular Pathology, Peter Maccallum Cancer Centre
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 29, 2024
All of Us Research Program, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces alanine with valine at codon 205 of the STK11 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with STK11-related disorders in the literature. This variant has been identified in 4/209296 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Uncertain:1Benign:2
Aug 23, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Jan 20, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nov 18, 2024
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jan 16, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 19892943, 26154128, 26010451, 15863673) -

not specified Benign:1
Apr 18, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: STK11 c.614C>T (p.Ala205Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.6e-05 in 1590130 control chromosomes (gnomAD v4.0.0). The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in STK11 causing Peutz-Jeghers Syndrome phenotype (6.3e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.614C>T in individuals affected with Peutz-Jeghers Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 142443). Based on the evidence outlined above, the variant was classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T;T;T
Eigen
Benign
0.18
Eigen_PC
Benign
0.18
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
D;D;D
M_CAP
Uncertain
0.22
D
MetaRNN
Uncertain
0.63
D;D;D
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.56
.;N;.
PhyloP100
7.8
PrimateAI
Pathogenic
0.79
T
PROVEAN
Uncertain
-3.1
.;D;.
REVEL
Uncertain
0.31
Sift
Uncertain
0.029
.;D;.
Sift4G
Benign
0.15
T;T;T
Polyphen
0.97
.;D;.
Vest4
0.72
MVP
0.68
MPC
1.9
ClinPred
0.66
D
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.36
gMVP
0.83
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587782468; hg19: chr19-1220596; COSMIC: COSV107372754; API